Topic resource collection
Approved comparison material connected to this topic.
30 resourcesRead both sides
Cerebrolysin BDNF and NGF upregulation through neurotrophin mimicry Neurotrophin signaling cascade 5–30 mL per session, 5 days/week for 4 weeks 7–14 days (working memory tasks) Best-supported clinical evidence for cognitive enhan…
The table below compares primary peptide classes used in glucose regulation research. Showing receptor targets, dosing ranges from published trials, expected glucose reduction, and key mechanistic differences. GLP-1 Agonists (sem…
CJC-1295 (with DAC) GHRH receptor agonist with albumin binding 6–8 days 1–2mg twice weekly Minimal. Transient injection site irritation Best for sustained baseline elevation; twice-weekly dosing offers convenience Modified GRF 1-…
Research protocols vary widely in how they structure glutathione and peptide co-administration. Concurrent dosing, sequential timing, and dose-dependent interactions all influence outcomes. The table below summarizes three common…
AOD-9604 Beta-3 adrenergic receptor agonist; activates HSL via cAMP/PKA pathway 2.6kg mean subcutaneous fat reduction (12 weeks, 10mg/day) No change in fasting glucose, insulin, or HbA1c Minimal; occasional injection-site erythem…
The following table compares semaglutide and tirzepatide across key research parameters: | Peptide | Receptor Target | Half-Life | Standard Maintenance Dose | Mean Body Weight Reduction (Clinical Trials) | GI Side Effect Incidenc…
BPC-157 Documented in research literature GI, tissue repair, systemic effects Native oral activity MK-677 (Ibutamoren) Documented oral activity GH-axis, sleep research Native oral activity (small molecule) KPV Partial research su…
GHK-Cu (Copper Peptide) Stimulates VEGF and TGF-β production; increases perifollicular capillary density Topical (1.5–3%) with microneedling 12–16 weeks Moderate. Multiple small-scale RCTs show 40–60% follicular density improveme…
GHK-Cu Collagen gene upregulation, MMP activation Extracellular matrix remodeling 1–2mg/day subcutaneous, 12 weeks 70% increase in collagen density (fibroblast studies); 18% improvement in cutometric elasticity Best evidence for …
Before selecting a peptide for metabolic research, compare mechanisms, half-lives, and dosing complexity to match your experimental design. AMPK Activators (AICAR) Direct AMPK phosphorylation → fatty acid oxidation, glucose uptak…